Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 239S · 10 late239 trades$59.22M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Tolia Nirav NDirector, CEO and President, 10% Owner | NXDRNextdoor Holdings, Inc. Tax withholding | F | $46K 17.8K sh | Oct 19, 2026 |
| 9 | Tolia Nirav NDirector, CEO and President, 10% Owner | NXDRNextdoor Holdings, Inc. Option exercise | M | — 110.5K sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Burnett VeraCFO and Treasurer |  EBFENNIS, INC.Option exercise | M | $35K 2,000 sh | Oct 19, 2026 traded Oct 19, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $824K 3,406 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $593K 2,439 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $332K 1,360 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $305K 1,246 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $294K 1,299 sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Dube Eric MDirector, CHIEF EXECUTIVE OFFICER |  TVTXTravere Therapeutics, Inc.Option exercise · 10b5-1 plan | M | $1.79M 200.0K sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Abbott Swati BargotraDirector |  ENSGENSIGN GROUP, INCGrant or award | A | — 600 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Disbrow Lisa SDirector |  CACICACI INTERNATIONAL INC /DE/Grant or award | A | — 418 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Sarvikas JuhoDirector, Chief Executive Officer |  INSGINSEEGO CORP.Tax withholding | F | $15K 3,657 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Cain James PDirector |  AREALEXANDRIA REAL ESTATE EQUITIES, INC.Grant or award | A | — 168 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Catalio Capital Management, LP10% Owner |  IAMIambic Therapeutics, Inc.Derivative conversion | C | — 742.5K sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Main Jennifer ElizabethDirector |  CTEVClaritev CorpGrant or award | A | — 3,113 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Vogelstein R JacobDirector | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 2.00M sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | McClaskey James PaulChief Accounting Officer | INSGINSEEGO CORP. Tax withholding | F | $1,930 465 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Vogelstein R JacobDirector | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 122.7K sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Han FeiChief Financial Officer |  DFDVDeFi Development Corp.Tax withholding | F | $11K 2,803 sh | Oct 19, 2026 traded Oct 17, 2026 |
| 9 | Catalio Capital Management, LP10% Owner | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 731.2K sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Tolia Nirav NDirector, CEO and President, 10% Owner | NXDRNextdoor Holdings, Inc. Option exercise | M | — 45.1K sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Thomsen Joel S.TRUSTEE | NONESterling Real Estate Trust Grant or award | A | $12K 479 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Lisowski CraigPresident of Products | NXDRNextdoor Holdings, Inc. Option exercise | M | — 178.6K sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Vogelstein R JacobDirector | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 742.5K sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Rachlin Evan LockwoodDirector | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 1.46M sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Chandrasena GillianSVP, Chief HR Officer |  MMEDMiniMed Group, Inc.Grant or award | A | — 1,800 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Disbrow Lisa SDirector | CACICACI INTERNATIONAL INC /DE/ Grant or award | A | — 50 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Lisowski CraigPresident of Products | NXDRNextdoor Holdings, Inc. Option exercise | M | — 41.4K sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $378K 1,608 sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Kiernan MichaelChief Revenue Officer | NXDRNextdoor Holdings, Inc. Option exercise | M | — 27.6K sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Johnson Christine ProcopioSVP, CSO |  KWRQUAKER CHEMICAL CORPGrant or award | A | — 504 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Vogelstein R JacobDirector | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 1.46M sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Catalio Capital Management, LP10% Owner | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 1.46M sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Catalio Capital Management, LP10% Owner | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 742.5K sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Catalio Capital Management, LP10% Owner | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 1.14M sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Vogelstein R JacobDirector | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 742.5K sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Rachlin Evan LockwoodDirector | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 410.8K sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Kiernan MichaelChief Revenue Officer | NXDRNextdoor Holdings, Inc. Option exercise | M | — 27.6K sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Vogelstein R JacobDirector | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 1.46M sh | Oct 19, 2026 traded Oct 16, 2026 |
| 8 | Lisowski CraigPresident of Products | NXDRNextdoor Holdings, Inc. Tax withholding | F | $96K 36.9K sh | Oct 19, 2026 traded Oct 15, 2026 |
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K